Global Cell Line Engineering Services Market Growth (Status and Outlook) 2023-2029

Global Cell Line Engineering Services Market Growth (Status and Outlook) 2023-2029

The global Cell Line Engineering Services market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Cell Line Engineering Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Cell Line Engineering Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Cell Line Engineering Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Cell Line Engineering Services players cover CD BioSciences, Curia, Horizo​​n Discovery, Multispan, Inc., System Biosciences (SBI), Biocon, Cyagen, Analytical Biological Services (ABS) and Celvab, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Cell line engineering services is a biotechnology service that utilizes gene editing and cell culture technologies to edit and modify cells for various research and application needs. In this service, professional scientists design suitable gene editing schemes based on the customer's requirements and use gene editing tools such as CRISPR/Cas9 to precisely modify, insert, or delete the target gene sequence. Through specific cell culture techniques, the modified cells can obtain superior phenotypes and characteristics, such as higher product yield, better growth characteristics, and higher immune response.

Cell line engineering services are mainly applied in the field of biomedicine, such as drug screening, immunotherapy, gene therapy, etc. Furthermore, since this technology can be applied to various types of cells and animal and plant cells, it can also be applied in fields such as food and agriculture, such as improving the disease resistance of some plants and improving the quality of certain meat products.

LPI (LP Information)' newest research report, the “Cell Line Engineering Services Industry Forecast” looks at past sales and reviews total world Cell Line Engineering Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell Line Engineering Services sales for 2023 through 2029. With Cell Line Engineering Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Line Engineering Services industry.

This Insight Report provides a comprehensive analysis of the global Cell Line Engineering Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell Line Engineering Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Line Engineering Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Line Engineering Services and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Line Engineering Services.

This report presents a comprehensive overview, market shares, and growth opportunities of Cell Line Engineering Services market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Small scale
Medium scale
Large scale

Segmentation by application
Bio-pharmaceutical
Medical Treatment
Medical Research
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
CD BioSciences
Curia
Horizo​​n Discovery
Multispan, Inc.
System Biosciences (SBI)
Biocon
Cyagen
Analytical Biological Services (ABS)
Celvab
Boston Institute of Biotechnology
ALSTEM
ProMab Biotechnologies
Cytosurge AG
Merck
Thermo Fisher Scientific
WuXi Advanced Therapies
GenScript Biotech Corporation (HK.1548)

Please note: The report will take approximately 2 business days to prepare and deliver.